Richard Goodwin

Richard Goodwin serves as the Global Head of Predictive AI & Data (Interim) at AstraZeneca, a position held since March 2011, alongside various leadership roles including Executive Director and Head of Discovery BioAnalysis in Integrated BioAnalysis (IBA), as well as Senior Director of Imaging & AI in Clinical Pharmacology & Safety Sciences. Richard is recognized for expertise in mass spectrometry imaging and has led multiple international collaborations to advance MSI methodologies. Prior to AstraZeneca, Richard contributed to research at the University of Glasgow as a Post Doc, focusing on MALDI-MSI technology to investigate drug distributions in parasitic research. Richard earned a PhD from The University of Edinburgh, specializing in microsampling and online separation techniques for mass spectrometry.